Home LiteratureArticle Details
PMID: 6171988 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Effect of prolonged and neonatal capsaicin treatments on the substance P immunoreactive nerves in the rabbit eye and spinal cord.

Acta ophthalmologica ·Vol. 59 ·No. 5 ·1981-10-00 ·Pages 737-46

Tervo K

Abstract

Substance-P (SP) immunoreactivity was demonstrated in the rabbit eye and spinal cord using monoclonal SP antibody and an indirect immunofluorescence technique. Norves containing SP immunoreactive material were found in the cornea, iris and ciliary body of which the iridic sphincter had the densest innervation. Neither prolonged subcutaneous treatment (up to 280 mg/kg) augmented by intracameral capsaicin injection nor neonatal treatment with drug 70 mg/kg eliminated this immunoreactivity, though both blocked the miotic effect of intracameral SP. It is concluded that capsaicin is not specific SP depleting agent but rather a neurotocic substance that affects noxious pathways and probably prevents the release of the SP retained by the nerve following the treatment used.

MeSH Terms
Animals Animals, Newborn Capsaicin/pharmacology Eye/immunology Fatty Acids, Unsaturated/pharmacology Fluorescent Antibody Technique Iris/drug effects,innervation Miotics/antagonists & inhibitors Rats Spinal Cord/drug effects,immunology Substance P/antagonists & inhibitors,immunology
Chemicals
Fatty Acids, Unsaturated Miotics Substance P Capsaicin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Tervo K
Article Info
Journal
Acta ophthalmologica
Abbr.
Acta Ophthalmol (Copenh)
ISSN
0001-639X
Published
1981-10-00
Pages
737-46
Language
English
Region
Denmark
NLM ID
0370347
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com